Skip to main content
. 2016 May 6;7(23):35313–35326. doi: 10.18632/oncotarget.9204

Figure 6. EGCG treatment decreases DNMT activity (DNMT1, DNMT3a, DNMT3b) in human colon cancer cell lines.

Figure 6

Replicates from biological duplicates are shown (mean ± SE; *p<0.01 5-AZA compared to EGCG – combined cell lines).